2021-11-12T14:59:21-06:00 2020-12-31 911194016 CLARK NUBER PS 10900 NE 4TH STREET SUITE 1400 BELLEVUE WA 98004 990 2020-01-01 911593913 GENEVA FOUNDATION GENE 2533831398 917 PACIFIC AVENUE NO 600 TACOMA WA 98402 BRENT DE ROSIA CHIEF FINANCIAL OFFICER 2533831398 2021-11-12 1 BRENT DE ROSIA 999009999 JENNIFER BECKER HARRIS P00183358 4254544919 2021-11-12 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z ELISE HUSZAR 917 PACIFIC AVENUE NO 600 TACOMA WA 98402 67284097 0 X WWW.GENEVAUSA.ORG X 1993 WA TO SUPPORT & ADVANCE INNOVATIVE MEDICAL RESEARCH & EXCELLENCE IN EDUCATION WITHIN THE U.S. MILITARY. 11 10 631 11 0 0 84071 98170 55854404 67012383 46387 38052 0 0 55984862 67148605 20000 0 0 0 31862296 34845689 0 0 74473 24417339 30542403 56299635 65388092 -314773 1760513 14865828 26807231 10312602 20383787 4553226 6423444 X THE GENEVA FOUNDATION IS A WA NOT-FOR-PROFIT CORPORATION THAT PROVIDES SCIENTIFIC, FINANCIAL, EDUCATIONAL, AND PROJECT MANAGEMENT SUPPORT TO THE US MILITARY MEDICAL COMMUNITY IN THE CONDUCT OF FEDERALLY FUNDED GRANTS AND CONTRACTS, INDUSTRY-SPONSORED CLINICAL TRIALS, AND EDUCATIONAL OPPORTUNITIES. GENEVA WAS ESTABLISHED IN 1993 TO FACILITATE MEDICAL RESEARCH IN MILITARY MEDICAL FACILITIES, INCLUDING RESEARCH PROPOSAL DEVELOPMENT AND PROGRAM MANAGEMENT SERVICES TO ADVANCE MEDICAL TREATMENTS AND SOLUTIONS FOR US SERVICE MEMBERS AND THEIR FAMILIES, VETERANS, AND THE GENERAL PUBLIC. 0 0 59461323 67012383 GENEVA IS A NON-PROFIT ORGANIZATION THAT ADVANCES MILITARY MEDICINE THROUGH STRONG FINANCIAL AND PROGRAM MANAGEMENT SERVICES. SINCE ITS INCEPTION IN 1993, GENEVA HAS MANAGED $502+ MILLION IN FEDERAL AND NON-FEDERAL FUNDS IN SUPPORT OF MILITARY RESEARCH AND EDUCATION. IN 2020, GENEVA SUPPORTED APPROXIMATELY 320 INDUSTRY-SPONSORED CLINICAL TRIALS AND FEDERAL AND NON-FEDERAL GRANT AND CONTRACT PROGRAMS AT OVER 50 MILITARY MEDICAL FACILITIES AND LABORATORIES WORLDWIDE. AS GENEVA CONTINUES TO GROW, WE REMAIN FOCUSED ON PROVIDING A HIGH LEVEL OF CUSTOMER SERVICE CUSTOMIZED TO INDIVIDUAL CLIENT NEEDS. THE CORPORATE OFFICE REMAINS SMALL WITH 75 PEOPLE WHO DIRECTLY SUPPORT THE WORK OF OVER 172 PROJECT-BASED EMPLOYEES AND 185+ INVESTIGATORS AT MILITARY SITES WORLDWIDE. GENEVA'S MULTI-FACETED COLLABORATIONS ALLOW US TO SUPPORT RESEARCH THAT DIRECTLY IMPACTS THE HEALTH AND SAFETY OF US ARMED FORCES AND VETERANS, THEIR BENEFICIARIES, AND THE PUBLIC. 59461323 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 134 0 631 1 0 0 0 0 0 0 0 0 0 0 0 0 X 11 10 0 0 1 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 WA X SHARON HAMILTON 2533831398 917 PACIFIC AVENUE SUITE 600 TACOMA WA 98402 ELISE HUSZAR PRESIDENT & CEO 40.00 X X 205384 0 11730 JANE TAYLOR CHIEF STRATEGY OFFICER 36.00 X X 177678 0 17853 FRANK SCOGGINS CHAIR 1.00 X X 0 0 0 NEIL VINING VICE CHAIR 1.00 X X 0 0 0 CW HERCHOLD TREASURER 1.00 X X 0 0 0 LISA COHEN SECRETARY 1.00 X X 0 0 0 KENNETH BERTRAM BOARD MEMBER 1.00 X 0 0 0 DAVID BLANFORD BOARD MEMBER 1.00 X 3900 0 0 ROSS COLT BOARD MEMBER 1.00 X 0 0 0 JOHN HORNICK BOARD MEMBER 1.00 X 0 0 0 STEPHEN LANZA BOARD MEMBER 1.00 X 0 0 0 CLIFF ROBERTSON BOARD MEMBER 1.00 X 0 0 0 BRENT DE ROSIA CHIEF FINANCIAL OFFICER 40.00 X 186104 0 17361 KELLI BLAIZE-WISE DIR. OF STRATEGIC PARTNERSHIPS 40.00 X 171350 0 17809 VICTORIA TEPE NEUROSCIENTIST II 40.00 X 178920 0 17794 ANDRIY BATCHINSKY DIR. OF STRATEGIC PARTNERSHIPS 40.00 X 277820 0 23295 STEPHEN FRANCESCONI PROGRAM MANAGER 40.00 X 174794 0 20838 BRAD ISAACSON PRINCIPLE INVESTIGATOR 40.00 X 190834 0 8568 1566784 0 135248 58 0 1 0 SCIPERIO INC 12151 RESEARCH PARKWAY SUITE 150 ORLANDO FL 32826 MEDICAL RESEARCH 5696407 THE GENERAL HOSPITAL CORPORATION 55 FRUIT STREET BOSTON MA 02114 MEDICAL RESEARCH 1905745 NATIONAL CANCER INSTITUTE NCI CENTER DRIVE BETHESDA MA 20892 MEDICAL RESEARCH 1313154 SARTORIUS STEDIM NORTH AMERICA INC 565 JOHNSON AVENUE BOHEMIA NY 11716 MEDICAL RESEARCH 684446 UNIVERSITY OF MIAMI PO BOX 405803 ATLANTA GA 30384 MEDICAL RESEARCH 615337 29 98170 98170 GOV'T & CONTRACT REV. 611710 65265155 65265155 CLINICAL STUDIES 611710 1573083 1573083 EDUCATION 611710 115234 115234 CONFERENCE & EXHIBIT 611710 58911 58911 67012383 20531 20531 153013 135492 17521 17521 17521 67148605 67012383 0 38052 X 610570 20568 570249 19753 25114346 22723611 2382672 8063 904889 818749 85849 291 5931045 5366445 562696 1904 2284839 2031249 251529 2061 67502 831 66671 85160 85160 15614831 15270102 344729 291905 221806 41253 28846 848524 505491 343033 1102045 793010 309035 316245 290010 24069 2166 101901 99711 2190 68082 68082 1121229 974784 146445 264788 264788 LAB COSTS 6946558 6897993 39669 8896 LAB SUPPLIES 3122964 3122964 EQUIPMENT 189528 189528 401141 134471 266367 303 65388092 59461323 5852296 74473 252500 250000 1000081 9367275 9985022 11486401 246997 484230 204940 178923 7581401 3620477 2243828 3960924 932460 1079478 14865828 26807231 5669025 7673176 2993577 4280599 0 2250127 1650000 6179885 10312602 20383787 X 3591340 3155421 961886 3268023 4553226 6423444 14865828 26807231 1760513 109705 0 X 0 1 X 1 1 1 X 21074 25641 164015 84071 98170 392971 54584447 53395277 51627202 55854404 67012383 282473713 54605521 53420918 51791217 55938475 67110553 282866684 11044 7526 18570 35508193 33545328 33111907 37055514 35944937 175165879 35508193 33545328 33111907 37066558 35952463 175184449 107682235 28141 35641 35164 27274 20531 146751 28141 35641 35164 27274 20531 146751 54633662 53456559 51826381 55965749 67131084 283013435 0.38050 0.47140 0.00050 0.00060 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 X 33891 20458 13433 7547510 3600019 3947491 3960924 67190228 109705 -68082 41623 67148605 0 67148605 65320010 0 65320010 68082 68082 65388092 PART IV, LINE 2B: GENEVA MANAGES THE TRISERVICE NURSING RESEARCH PROGRAM (TSNRP) ON BEHALF OF THE DEPARTMENT OF DEFENSE. WE STAFF THE PROGRAM MANAGEMENT OFFICE AND OVERSEE THE EXECUTION OF RESEARCH AWARDS TO MILITARY NURSES AND GRADUATE STUDENTS. WE ALSO ENSURE THAT THE MISSION OF TSNRP IS CARRIED OUT IN ACCORDANCE WITH ITS EXECUTIVE DIRECTOR AND EXECUTIVE BOARD OF DIRECTORS. PART XI, LINE 2D - OTHER ADJUSTMENTS: INTEREST EXPENSE -68,082. PART XII, LINE 4B - OTHER ADJUSTMENTS: INTEREST EXPENSE 68,082. EAST ASIA AND THE PACIFIC 0 1 PROGRAM SERVICES RESEARCH 510928 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES RESEARCH 550444 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 FUNDRAISING 0 1 0 0 0 1 1061372 0 1061372 1 0 0 0 0 0 PART I, LINE 3: THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR EXPENDITURES. PART III ACCOUNTING METHOD: SCHEDULE F, PART IV, LINE 1 THERE WERE TRANSFERS TO FOREIGN CORPORATIONS, BUT THEY WERE NOT OF THE TYPE DESCRIBED IN SECTION 6038B(A)(1)(A), 367(D), OR 367(D) SO NO FORM 926 WAS REQUIRED TO BE FILED. 1 X X 1 0 0 0 0 0 0 1 0 ANDRIY BATCHINSKY DIR. OF STRATEGIC PARTNERSHIPS 277820 0 0 0 0 0 13000 0 10295 0 301115 0 0 0 ELISE HUSZAR PRESIDENT & CEO 205234 0 150 0 0 0 10180 0 1550 0 217114 0 0 0 BRENT DE ROSIA CHIEF FINANCIAL OFFICER 185954 0 150 0 0 0 9233 0 8128 0 203465 0 0 0 BRAD ISAACSON PRINCIPLE INVESTIGATOR 190834 0 0 0 0 0 7586 0 982 0 199402 0 0 0 VICTORIA TEPE NEUROSCIENTIST II 178920 0 0 0 0 0 8907 0 8887 0 196714 0 0 0 STEPHEN FRANCESCONI PROGRAM MANAGER 174794 0 0 0 0 0 8680 0 12158 0 195632 0 0 0 JANE TAYLOR CHIEF STRATEGY OFFICER 97404 0 100 0 80174 0 8744 0 9109 0 195531 0 0 0 KELLI BLAIZE-WISE DIR. OF STRATEGIC PARTNERSHIPS 171200 0 150 0 0 0 8508 0 9301 0 189159 0 0 0 PART I, LINE 4A JANE TAYLOR RECEIVED SEVERANCE PAY OF $80,174 IN 2020. PART I, LINE 7 THE LEADERSHIP TEAM DETERMINED A BONUS FOR CERTAIN INDIVIDUALS WAS REASONABLE COMPENSATION FOR THE UNPRECEDENTED COVID-19 WORKLOAD, TURNOVER WORKLOAD, AND REORGANIZATION CHALLENGES. FORM 990, PART I, LINE 6: GENEVA'S BOARD OF DIRECTORS IS COMPRISED OF INDIVIDUALS FROM MILITARY, MEDICAL, AND BUSINESS BACKGROUNDS WHO VOLUNTEER THEIR TIME TO FURTHER GENEVA'S MISSION AND ENSURE THE LONG TERM SUSTAINABILITY OF THE ORGANIZATION. THE BOARD OF DIRECTORS IS DEPICTED ON GENEVA'S WEBSITE ANNUALLY. THE AVERAGE NUMBER OF HOURS PER QUARTER IS 1 HOUR PER VOLUNTEER SINCE 2017. FORM 990, PART VI, SECTION A, LINE 4 THE BYLAWS WERE UPDATED TO ALLOW THE ELECTION OF NEW BOARD DIRECTORS AT ANY BOARD MEETING AND TO CLARIFY THAT THE BOARD TERMS WILL BE COUNTED FROM THE BEGINNING OF THE CALENDAR YEAR IN WHICH THE NEW MEMBER JOINS THE BOARD. FORM 990, PART VI, SECTION B, LINE 11B THE CONTROLLER AND CHIEF FINANCIAL OFFICER REVIEW THE ACCURACY OF THE COMPLETED FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C COVERED PERSON ARE REQUIRED TO SIGN CONFLICT OF INTEREST STATEMENTS WHEN THEY JOIN THE FOUNDATION. "COVERED PERSONS" ARE A SUBSET OF GENEVA AFFILIATES DEFINED AS ANY GENEVA DIRECTOR, OFFICER, KEY EMPLOYEE OR MEMBER OF ANY BOARD-CREATED COMMITTEE. THE BOARD OF DIRECTORS AND THE PRESIDENT DETERMINE WHEN A CONFLICT OF INTEREST EXISTS. THE MAJORITY OF THE BOARD OF DIRECTORS, WHO HAVE NO INTEREST IN THE TRANSACTION OR ARRANGEMENT, WILL REVIEW ANY CONFLICTS OF INTEREST. ANY GENEVA AFFILIATE WHO HAS AN ACTUAL OR POTENTIAL CONFLICT WITH RESPECT TO THE TRANSACTION OR ARRANGEMENT DOES NOT PARTICIPATE IN AND IS NOT PRESENT FOR THE VOTE REGARDING ANY SUCH TRANSACTION OR ARRANGEMENT (PROVIDED, HOWEVER, THAT ANY SUCH GENEVA AFFILIATE MAY APPEAR AT A MEETING TO ANSWER QUESTIONS CONCERNING THE TRANSACTION OR ARRANGEMENT.) THE BOARD WILL MAINTAIN A FILE OF ALL REAL OR POTENTIAL CONFLICTS RAISED BEFORE THE BOARD. IF THE BOARD OF DIRECTORS HAS REASONABLE CAUSE TO BELIEVE THAT A GENEVA AFFILIATE HAS FAILED TO COMPLY WITH THIS POLICY, THE BOARD MAY COUNSEL THE GENEVA AFFILIATE REGARDING SUCH FAILURE AND, IF THE ISSUE IS NOT RESOLVED TO THE BOARD'S SATISFACTION, MAY CONSIDER ADDITIONAL CORRECTIVE ACTION AS APPROPRIATE. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS COMPLETES A PERFORMANCE EVALUATION ON THE PRESIDENT OF THE COMPANY TO ESTABLISH THE COMPENSATION FOR THE NEW EVALUATION PERIOD. THE AMOUNT IS SUBMITTED AS PART OF THE OPERATING BUDGET AND APPROVED BY THE BOARD OF DIRECTORS. THE OPERATING BUDGET IS DEVELOPED BY THE EXECUTIVE TEAM AND DEPARTMENT DIRECTORS. THE PRESIDENT ESTABLISHES COMPENSATION FOR KEY PERSONNEL USING SALARY COMPARISONS OF LIKE POSITIONS IN THE REGION. THE OPERATING BUDGET IS PRESENTED TO THE BOARD OF DIRECTORS FOR THEIR REVIEW AND APPROVAL WITH THE FULL DISCLOSURE OF COMPENSATION TO THE PRESIDENT OF THE BOARD. THE LAST COMPENSATION REVIEW WAS COMPLETED NOVEMBER OF 2020. FORM 990, PART VI, SECTION C, LINE 19 THE AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC BY REQUEST AND APPROVAL BY THE EXECUTIVE TEAM. THE GOVERNING AND ORGANIZING DOCUMENTS ARE AVAILABLE UPON REQUEST. CONFLICT OF INTEREST STATEMENTS ARE MAINTAINED ON FILE WITH THE FOUNDATION AND MAY BE VIEWED UPON REQUEST AND AUTHORIZATION BY THE FOUNDATION'S LEADERSHIP. FORM 990, PART IX, LINE 11G RESEARCH EXPENSES: PROGRAM SERVICE EXPENSES 596,493. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 596,493. SUBCONTRACTORS: PROGRAM SERVICE EXPENSES 14,673,609. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 14,673,609. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 344,729. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 344,729.